Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,611 across all filing types
Latest filing 2022-08-17 Investor Presentation
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
本公司受邀參加國票綜合證券舉辦之法人說明會
Investor Presentation Classification · 90% confidence The document is a short announcement (664 characters) about the company 1734 杏輝 being invited to participate in an investor presentation hosted by a securities firm. It includes details such as date, time, location, and a brief description of the event content (company operations and business information). There are no financial statements or detailed financial data included. The document serves as a notice of an upcoming investor presentation rather than the presentation itself or a financial report. Therefore, it fits best under the category of Investor Presentation (IP). Given the short length and nature, it is not a report publication announcement or regulatory filing. Confidence is high due to clear indicators of an investor presentation event.
2022-08-17 Chinese
111年第2季海外子公司投資
Regulatory Filings Classification · 90% confidence The document is a financial disclosure from a publicly listed company (杏輝) showing investment details in overseas subsidiaries for the second quarter of the 111th year (likely referring to a fiscal quarter). It includes investment amounts, shareholding percentages, and recognized investment gains or losses. The document length is short (1067 characters) and it primarily contains tabular data on investments without comprehensive financial statements or management discussion. It does not appear to be a full interim or annual report but rather a regulatory disclosure of investment holdings and results. Given the nature and length, this fits best as a Regulatory Filing (RNS) rather than a full Interim Report (IR) or Annual Report (10-K).
2022-08-12 Chinese
111年第2季大陸投資
Regulatory Filings Classification · 90% confidence The document is a detailed tabular disclosure of investment amounts and related financial figures concerning the company's investments in mainland China. It includes specific financial data such as capital amounts, investment methods, cumulative investment amounts, shareholding percentages, and recognized investment gains or losses. The document also contains explanatory notes about the investment methods and accounting bases for investment gains. The length is 1501 characters, which is relatively short but contains substantive financial data rather than just an announcement or certification. The content is consistent with a regulatory disclosure of investment details rather than a full annual or quarterly report. Given the nature of the data and the context, this document fits best under Regulatory Filings (RNS), as it is a regulatory disclosure of investment information that does not fit into other more specific categories like Annual Report or Interim Report.
2022-08-12 Chinese
111年第2季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in equity for a specific half-year period (民國111年上半年度, which corresponds to the first half of 2022). It includes line items such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, and other equity components. The presence of comparative data for the previous half-year period (去年同期) further supports that this is a financial report covering a period shorter than a full fiscal year. The document length is 3754 characters, which is relatively short but contains substantive financial data, not just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR) rather than an Annual Report or a simple announcement. There is no indication that this is a full annual report (10-K) or an earnings release (ER) which typically are more summarized. The detailed equity changes and financial data align with an interim report.
2022-08-12 Chinese
111年第2季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the period from January 1 to June 30, 2022 (111年第2季 in the Taiwanese calendar). It includes detailed financial data such as cash flows from operating, investing, and financing activities, with specific amounts and accounting items. The document length is 2360 characters, which is relatively short but contains substantive financial data rather than just an announcement or a link to a report. The presence of actual financial statements for a half-year period indicates this is an Interim / Quarterly Report. There is no indication that this is merely a report publication announcement or a certification. Therefore, the document should be classified as an Interim / Quarterly Report (IR).
2022-08-12 Chinese
111年第2季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data including consolidated income statements for the second quarter and half-year periods of the fiscal year 111 (which corresponds to 2022 in the Gregorian calendar). It includes actual financial figures such as revenue, costs, operating profit, net profit, and earnings per share. The presence of comprehensive financial data for a specific quarter and half-year period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 3712 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2022-08-12 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.